Top Markets
#1 PulseChain PulseChain +45.01%
#2 Glidr Glidr +20.14%
#3 eCash eCash +9.77%
#4 Fake World Assets Fake World Assets +9.33%
#5 Ribbita by Virtuals Ribbita by Virtuals +8.73%
#6 Meteora Meteora +8.31%
#7 OPENLOOT OPENLOOT +8.22%
#8 Cash Cat Cash Cat +7.80%
#9 Verus Coin Verus Coin +7.70%
#10 Ergo Ergo +7.30%
Coin of the day
PulseChain PulseChain
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Oxygenta Pharmaceutical Ltd. Oxygenta Pharmaceutical Ltd.

Oxygenta Pharmaceutical Ltd.

OXYGENTAPH
Clasificación en acciones #28278
Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of... Oxygenta Pharmaceutical Ltd. focuses on the formulation and production of active pharmaceutical ingredients. Their offerings specifically encompass medications used to treat ulcers and fight bacterial infections. The company commenced operations on November 27, 1990, and maintains its primary base in Hyderabad, India.
Precio por acción
$0.74183167
Última sincronización: 2026-08-19
Capitalización bursátil
$27.44M
Cambio (1 día)
-0.01%
Cambio (1 año)
-20.70%
País
IN
Comercio Oxygenta Pharmaceutical Ltd. (OXYGENTAPH)

Categoría

Healthcare
Ratio P/B de Oxygenta Pharmaceutical Ltd. (OXYGENTAPH)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Oxygenta Pharmaceutical Ltd., el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Oxygenta Pharmaceutical Ltd. desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 3.817 -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 2.4038 -
HK
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 17.0911 -
US